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ABSTRACT
Background: Improve educational experience, teaching effectiveness and learning outcomes remains one of 
the major educational challenges nowadays. Purpose: To determine the effect of organizing and teaching the 
Pharmaceutical Drug Development curricular unit using a Multi-method Active Learning Approach, MALA, as 
a novel teaching/learning strategy. Methods: MALA involved several different activities about pharmaceutical 
legislation, medicines production and validation process, Common Technical Document, and others, and the 
evaluation of this active learning approach was made in two ways: students’ performance (grades), and students’ 
evaluation regarding the curricular unit and the teachers’ performance.  Results: Results revealed two main 
important aspects of the implementation of MALA: (i) the implementation of MALA showed high rates of students’ 
satisfaction regarding the curricular unit and teachers’ performance; (ii) student’s performance (grades) were very 
high, revealing excellent teaching/ learning results. Conclusion: The present study fostered the concept that the 
MALA- learning approach should contribute to knowledge- enhancing in the pharmaceutical practice and could 
encourage integration of the students' learning skills in the future career, thus stimulating the flexibility in learning.
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Improve educational experience, teaching 
effectiveness and learning outcomes (LO) 
remains one of  the major educational chal-
lenges nowadays. Surrounding pharmaceu-
tical education, the Accreditation Council 
for Pharmacy Education refers that it is 
fundamental to implement active learning 
methods in under graduation process to 
improve learning outcomes.1
Pharmaceutical Drug Development (PDD) 
constitutes a challenging subject to be 
learned by the undergraduate students who 
face difficulties in the integration of  the 
theoretical and practical concepts of  the 
discipline. Traditional learning methods are 
characterized by the simple transmission of  
information (theoretical lectures and teach-
ing materials) and an exam at the end of  the 
semester.
Active learning approaches, as prob-
lem-based learning (PBL), have been 
developed and widely used in higher 
education,2 aiming to improve the edu-
cational experience and outcomes in 
opposition to the traditional methods. 
Firstly, these learning processes pretend 
to be active efforts and the student must 
learn in different ways.3 This learning 
technique is based on four key principles 
(constructive, self-directed, collaborative 
and contextual learning process) and it 
implies the verbalization, co-construc-
tion, joint support and appreciation 
between the participants.4 Here students 
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discover, research, process and apply information,5 
and also play a pivotal role on planning, monitoring 
and evaluating the educational method.6,7 The char-
acteristics considered essential in the PBL method 
are the problems as an incentive for learning, tutors 
as facilitators and group working as motivation for 
interaction, where tutors and consultants should 
stimulate students towards self-directed learning 
and to explore the knowledge profoundly.4
Accordingly, in 2006, the Health Sciences Department 
of  Aveiro University (UA) applied a multi-method 
active learning approach (MALA)8 in the PDD cur-
ricular unit (CU) instead of  teaching in a traditional 
manner. Thus, the objectives of  the study were to 
determine the effect of  organizing and teaching the 
PDD unit using the MALA as a novel teaching/learn-
ing strategy and to assess Biomedical Sciences degree 
students´ performance and evaluation towards this 
learning process.
MATERIALS AND METHODS
Educational setting, study population and study 
period
In 2006, the Health Sciences Department of  UA 
adopted MALA8 in the Biomedical Sciences under-
graduate degree. The MALA was thus implemented in 
the PDD-CU of  the second year Biomedical Sciences 
degree at the UA. The PDD unit was initiated in the 
year 2007/2008 comprising 15 students. The second 
year edition, in 2008/2009, accounted for a total of  12 
students, the third edition, in 2009/2010, involved a 
group of  13 students, the fourth edition, in 2010/2011, 
included 16 students, and the fifth edition included 
19 students (2012/2013). In 2011/2012, PDD wasn’t 
taught because of  restructuring matters of  the Biomedi-
cal Sciences Degree.
It is important to refer that MALA was implemented in 
the first year of  the Biomedical Sciences degree. There-
fore, the second-year undergraduate students were 
familiar with this active learning method.
The traditional method
Traditionally, PDD is taught through lectures and the 
assessment is performed at the end of  the semester, 
when students face with a great volume of  new con-
cepts that should be memorized and understood in a 
short period of  time, increasing the difficulty of  trans-
pose theoretical concepts into practice. Moreover, the 
lack of  motivation, participation and autonomy can 
contribute to the failure of  the learning process.
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The preceptor responsible for the PDD- CU is a scien-
tific expert in pharmaceutical sciences, with expertise in 
Regulatory Affairs from Portuguese Pharmacists’ Pro-
fessional Organization. 
In order to implement MALA, competence- based LO 
were defined and structured by the consultant, which 
implied the transference of  the learning conscientious-
ness to the learners.9 Consultant defined the LO accord-
ing with the syllabus defined in the Biomedical Sciences 
degree.  
Table 1 presents the competences, LO and specific 
objectives related to each PAT (Performance, Attributes 
and Tasks) defined for this CU. Also, for each PAT, was 
defined the learning activity, the learning approaches 
used and the skills development pretended (Table 2). 
The MALA included four main activities (Figure 1):
Tutorial sessions
The course unit on PDD included tutorial sessions (TS) 
dealing with the general context of  the CU. The intent 
was to stimulate the students to ascertain about the sub-
ject, and also to promote independent study and active 
research:
● The first problem (Problem 1) presented to the 
students addressed the competencies and activi-
ties of  the institutions that regulate the pharma-
ceutical activity in terms of  National regulation, 
National Authority of  Medicines and Health 
Products I.P. (INFARMED), along with Euro-
pean regulation, European Medicines Agency 
(EMA), as well as the guidelines for Technical 
Requirements for Registration of  Pharmaceu-
ticals for Human Use, referred in the Interna-
tional Conference of  Harmonization (ICH);
● The second problem (Problem 2) addressed 
the European legislation, Eudralex (Volume 2), 
of  Pharmaceutical Legislation, Notice to appli-
cants and regulatory guidelines medicinal prod-
ucts for human use, presentation and content 
of  the Common Technical Document (CTD), 
procedures for marketing authorization, varia-
tions and renewal of  CTD. Given the specific-
ity of  the proposed problem, adaptations were 
made accordingly to the students’ difficulties in 
the resolution of  Problem 1.
The PBL sessions started with the discussion of  prob-
lems, to clarify the incomprehensible terms and con-
cepts, followed by the definition of  the problem by the 
students. The problems were further critically analyzed, 
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Table 1: Competences, learning outcomes, and specific objectives related to Pharmaceutical Drug Development.
Competency Learning outcome (LO) Performance, 
Attributes and 
Tasks (PAT)
Specific learning objectives 
To identify the 
European and 
National institutions 
that regulate the 
drug marketing 
authorization  
To identify the National 
and European 
institutions that regulate 
the introduction of a 
drug in the market 
and to recognize their 
competences
PAT 1 To identify National Authority of Medicines and Health Products, 
IP (INFARNED*) as the agency responsible for  monitor, assess 
and regulate all activities relating to human medicines and health 
products for the protection of Public Health
To identify the European Medicines Agency (EMA†), 
decentralized body of the European Union responsible for 
medicines regulation
To recognize the INFARMED IP competencies 
To  recognize the EMA competencies 
To identify and recognize  
the National and 
European legislation 
of pharmaceutical drug 
development 
PAT 2 To use informatics tools to  research, and collect  regulation  
and technical- scientific information  in the pharmaceutical 
development 
To identify and recognize the national legislation that regulates 
pharmaceutical development 














products” – Module 
3 of CTD
To recognize the 
Common Technical 
Document (CTD‡) in 
particular the format and 
content of module 3 of 
the CTD
PAT 3 To recognize the CTD 
To recognize the format and content of module 3 
To be able to research and analyze the information related with 
the parameters defined in module 3 
To evaluate, organize 
and construct the 
information related with 
the parameters referred in 
module 3 of the CTD
PAT 4 To organize and construct module 3, with the information 
obtained through the active substance identification and assay 
according to the European Pharmacopeia 
To know the concept of the manufacturing process validation 
To know the concept of analytical procedure validation 
To know the regulation for the stability protocol development 
* INFARMED, National Authority of  Medicines and Health Products, IP; EMA†, European Medicines Agency; ‡CTD, Common Technical 
Document
Figure 1: Multi-method active learning approach (MALA) activities
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thus activating prior knowledge that facilitates the pro-
cessing and clarification of  new information. 
Project
As a complementary approach in the PDD unit, it was 
proposed to the students that they should develop a 
project covering a specific subject within the framework 
of  the CU. Therefore, students were invited to examine, 
in detail an active substance mentioned in the European 
Pharmacopeia. Tutor supported the project progress, by 
directing the research to specific paths, and to accom-
plish specific objectives within the scheduled deadline. 
In addition, students were instigated to follow a line of  
research within the recommended literature. Founded 
on the literature review, it was defined the production 
of  a written report, correspond to the module 3 of  the 
CTD, to be presented to the rest of  the class in Power-
Point format. Both the written report and the oral pre-
sentation were communicated in the English language, 
and the latter had the duration of  10 minutes with 5 
minutes of  open discussion with the rest of  the class. 
This process was monitored by the tutor and contrib-
uted to an open line of  communication. 
The evaluation factor included, not only, the perfor-
mance during the presentation, but also, the active partic-
ipation in the discussion of  other groups´ presentations. 
Since the class was divided into groups, it was ensured 
that all students had the opportunity to actively partici-
pate in each project presentation, to learn more about a 
specific subject matter, and to develop their capacity of  
interaction and mutual aid within the group. Also, the 
students acquired relevant knowledge about panoply of  
subjects, and developed skills closely related to critical 
opinion. 
Seminars
Three seminars were included in the CU:
● Pharmacopeias: the first seminar was given by 
a pharmacist with a doctoral degree in Pharma-
ceutical Sciences. This seminar was dedicated 
to the Pharmacopeias, and students had the 
opportunity to consult and interpret the infor-
mation mentioned in the Pharmacopeias. The 
students dealt with the European, Portuguese, 
British and United American Pharmacopeia, 
denoting the particularities of  each one.
● CTD: the second seminar was given on the 
theme CTD by a specialist in Pharmaceutical 
Regulatory Affairs. During the seminar, the spe-
cialist focused on the five modules of  the CTD, 
especially, module 3, demonstrating with practi-
cal information.
● Validation of  analytical procedures and manu-
facturing process: the third seminar approached 
the validation process and was given by a Chem-
ical Engineer/Pharmacist working in a Pharma-
ceutical company.
Field-trip
Complimentarily, the PDD unit comprised a field-trip 
to a pharmaceutical enterprise where the students had 
contact with the drug manufacturing process. More-
over, the students were invited to integrate the process 
of  quality control, collecting and analyzing the samples 





Learning approaches Skills development 
Problem 1 Problem 2 Project CEA§
PAT 1 x x Problem-based learning a 
a) Reflection, reasoning, discussion, 
analysis, synthesis, critical thinking, 
information access and retrieval and oral 
communication skills.  
 
b) Listening, reflection, discussion, 
analysis, synthesis.  
 
c) Procedural and practical skills, 
observational skills and interpretative 
skills.  
 
d) Critical thinking, information 
access and retrieval, oral and written 
communication, capacity to explore
PAT 2 x x Problem-based learning a
PAT 3 x x x Problem-based learning a
Expert- driven learning b
Hands on experience c
PAT 4 x x Expert- driven learning b
Hands on experience c
Learning by teaching d
§CEA (Complementary Education Activities).
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(in-process control), under the supervision of  the head 
of  department. These activities were of  extraordinary 
importance, allowing the in loco visualization of  the 
manufacturing equipment, procedures and general work 
environment. The students also had the opportunity to 
recognize the process underlying to the stability, con-
trol of  the drug manufacturing rooms (including the 
temperature, humidity, and pressure), the water qual-
ity control, plus the complete circuit of  raw-materials 
entrance and the outlet of  the finished-product. Over-
all, the students were allowed to explore the main quality 
procedures, the good-quality laboratory practices, man-
ufacturing and warehouse of  the drugs, so they could 




Different assessment tools were used for each PAT 
(Table 3). The evaluation was defined at the begin-
ning of  the year, and presented to the students on the 
first day of  classes, as well as the tutorial chronogram, 
project work, field- trip and seminars, programmatic 
contents, and recommended literature. In relation to 
the assessment, 20% of  the evaluation corresponded 
to TS, through a schedule grid previously established 
for this type of  assessment that contemplated, among 
other factors, the following: assiduity, punctuality, indi-
vidual work, sharing/analysis/synthesis and integration 
of  information. The remaining 80% were distributed in 
the PAT component, more specifically PAT 1, 2, and 3, 
which were evaluated by final exam and had a weighting 
factor of  1, and PAT 4, that was assessed by the projects 
elaboration and presentation and had a weighting fac-
tor of  2. These techniques are integrated in the active 
learning, where the students are profoundly involved, 
over simply listening to a lecture, thus developing 
skills involved in higher- order thinking, and students 
embrace activities (analysis/discussion/evaluation) to 
explore their own attitudes and values.
Table 3: Performance, Attributes and Tasks assessment
Performance, Attributes and Tasks (PAT) Satisfaction Criteria 
PAT 1 Fair To identify the acronyms/meaning and to recognize the competences related 
to national pharmaceutical drug development. 
Good Additionally to the above requirements, this should be extended to the 
European pharmaceutical drug development. To recognize several actuation 
areas of INFARMED*, directly related to pharmaceutical drug development: 
marketing authorization submission process, variations and renewal 
requirement. 
Very Good Additionally to the above requirements, to know the different competences 
areas of EMA†, directly related to pharmaceutical drug development: marketing 
authorization submission process, variations and renewal requirement.
Excellent Additionally to the above requirements, to describe the competences of those 
institutions in relation to other actuation areas, such as: reimbursement and/or 
pharmacovigilance and/or inspection. 
PAT 2 Fair To recognize the INFARMED site, and the current National legislation (Dec. 
Lei 176/2006 of 30th August) in pharmaceutical development area. 
Good Additionally to the above requirements, to know the EMA and ICH site, the 
European legislation in the pharmaceutical drug development “Medicinal 
Products for Human Use” and guidelines. 
Very Good Additionally to the above requirements, to identify at the INFARMED and 
Informed website, compiled information. 
Excellent Additionally to the above requirements, to consult the EMA site in relation 
to the legislation, and information about the commercialized drug in the EU 
countries. 
PAT 3 Fair To identify module 3 of the CTD‡, either in the national or European legislation. 
Good Additionally to the above requirements, to know the 5 modules of the CTD, 
and in relation to module 3, recognize the format, index and content, either in 
the National and European legislation. 
Very Good Additionally to the above requirements, to be able to research information 
about the construction of module 3. 
Excellent Additionally to the above requirements, and in relation to module 3 of the CTD, 
to be able to analyze the information obtained by bibliographic research. 
Continue....
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About students’ global evaluation (grades of  the year), 
it was made using a quantitative scale, from 0 to 20, 
which converge the evaluation of  each PAT and the 
tutorial sessions. Five years were available for the analy-
sis: 2007/2008, 2008/2009, 2009/2010, 2010/2011 and 
2012/2013.
Students’ evaluation
UA recently implemented a quality assurance system 
that included students´ opinion about the CU and about 
teachers’ performance. Students were asked to respond 
to a questionnaire where each question was rated on 
a 9-point Likert scale, from 1 (disagree) to 9 (agree). 
Three years were available for the analysis: 2009/2010, 
2010/2011 and 2012/2013. The quality assurance sys-
tem was only implemented in the second semester of  
2008/2009, and because of  it, we don’t have results 
from 2007/2008 and 2008/2009 (PDD is a CU from 
the first semester).
The students’ opinion regarding the CU was evaluated 
in five different variables:
A. Global functionality of  the CU; 
B. Adequacy of  the CU proposed activity to the 
defined objectives; 
C. Students’ assiduity degree with the tutorial 
classes;
D. Global satisfaction degree concerning student 
performance;
E. Motivation to the CU.
The students’ opinion regarding the teachers’ perfor-
mance was evaluated in four different variables:
i. Global evaluation of  the teacher’ performance;
ii. Fulfillment of  the evaluation standing rule 
according to the students; 
iii. Relationship between the students and teacher; 
iv. Creation of  learning favorable atmosphere.
RESULTS
Students’ performance
About students’ grades, in 2007/2008 the mean was 
14, in 2008/2009 was 14.8, in 2009/2010 was 16.1, in 
2010/2011 was 15.4 and in 2012/2013 was 15.8. In gen-
eral, the grades have increased during the years and in 
2009/2010 we have obtained the highest classification 
(16.1).
Figure 2 presents the distribution of  students grades 
on a qualitative scale obtained in the different compo-
nents of  PAT evaluated in the PDD- CU. Comparing 
students’ performance in each PAT, PAT 1 and PAT 4 
revealed higher rates in all years analyzed.
Students’ evaluation
In relation to questionnaires, the results were transposed 
into a percentage (Figure 3). 
As demonstrated for all years analyzed, students’ evalu-
ation was higher than 70% for all variables analyzed. 
About the CU evaluation, students’ assiduity degree 
with the tutorial classes (C) and global satisfaction 
degree concerning student performance (D) present a 
rate superior of  75%. Teachers’ performance evaluation 
Table 3: Performance, Attributes and Tasks assessment ...... (Continue...)
Performance, Attributes and Tasks (PAT) Satisfaction Criteria 
PAT 4 Fair To recognize the module 3 of the CTD, in format, index, and content, 
and to be able to organize and construct, in correct technical- scientific 
English: 1) the general information about the active substance (structural 
elucidation, impurity and other characteristics; 3) active substance control 
(specifications, analytical procedures; 3) bibliographic references. 
Good Additionally to the above requirements, and in relation to module 3 of 
the CTD, to construct the information concerning: 1) complete product 
description and composition; 2) pharmaceutical development; 3) complete 
product control/ drug (specifications/ analytical procedure; 4) final product 
container.
Very Good Additionally to the above requirements, and in relation to module 3 of the 
CTD, to construct the information related to: 1) active substance synthesis 
process; 2) complete product/drug manufacturing process; 3) stability 
protocol. 
Excellent Additionally to the above requirements, in relation to module 3 of the CTD, 
to construct the information related to: analytical procedure validation for 
the active substance and the complete product; 2) manufacturing validation 
process, according to module 3 of the CTD. 
* INFARMED, National Authority of  Medicines and Health Products, IP;†EMA, European Medicines Agency; ‡CTD, Common Technical 
Document
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revealed for all variables, in 2009/2010 and 2010/2011, 
satisfaction levels higher than 80%. Comparing all years 
analyzed, the level of  students’ satisfaction decreases, in 
general, over time.
DISCUSSION
This study examines the effectiveness of  using MALA as 
a novel learning approach for PDD, and two main con-
clusions can be made: (i) the implementation of  MALA 
revealed high rates of  students’ satisfaction regarding 
the CU and teachers’ performance; (ii) student’s perfor-
mance (grades) are very high revealing excellent teach-
ing/learning results.
Our results revealed that the quantitative evaluation of  
the students’ performance increased over time, from 14 
(2007/2008) to 15.8 (2012/2013). It’s also important to 
refer that higher rated PAT’s were the PAT 1 and PAT 
4. PAT 1 is related to Portuguese legislation surround-
ing medicines, which is very interesting for the students, 
and PAT 4 is about the project elaboration, which con-
cern the practical application of  the knowledge acquired 
before. 
The PDD unit was re-structured and taught accordingly 
with this innovative learning strategy, comprising a vari-
ety of  active- learning educational techniques organized 
following the PBL method associated with complemen-
tary education activities (CEA), thus including problems 
on the subject matter, and a project consisting in the 
elaboration of  the model on the CTD. Moreover, the 
CU was complemented with seminars presented by spe-
cialists on drug development/regulatory affairs, and a 
field- trip to the pharmaceutical industry of  drug manu-
facturing.
The PBL learning approach encouraged students 
to integrate preliminary explanations and formulate 
learning questions as suggested in several studies.10-13 
Complementarily, students enhanced the self- directed 
learning skills in the sense that it improved the exploita-
tion of  literature to access information, thus addressing 
the proposed LO.4,13 Effectively, in 2005, Dolmans et al.4 
revealed that learning, in the context of  PBL, stimu-
lates the transference of  knowledge, and motivates self- 
directed and lifelong learning. Furthermore, the number 
of  students that attended the PBL sessions was crucial 
to the success of  the learning process.14
Figure 2: Distribution of students´ grades (qualitative scale) obtained in the different Performance, Attributes and Tasks (PAT) 
evaluated.
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Figure 3: Quality assurance system: Curricular Unit (CU): A. Global functionality of the CU; B. Adequacy of the CU proposed 
activity to the defined objectives; C. Students assiduity degree to the tutorial classes; D. Global satisfaction degree concerning 
student performance; E. Students motivation for the CU. Teachers’ performance: I. Global evaluation of the teacher performance; 
II. Fulfillment of the evaluation standing rule agreed with de students; III. Relationship between students and teacher; IV. Creation 
of a learning favorable atmosphere and to the active students participation.
MALA - Multi-method active learning approach
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Given that the number of  student we had exceeded 
the optimal quantity, as discussed above, we decided, 
by preceding experience, that it was advisable to have 
two smaller groups, thus comprising 6-8 students each 
group in the same classroom.14 The main reason for 
this preference was that, in smaller groups, the infor-
mation was easily exchanged between all students. 
None the less, our teaching experience leads us to 
consider that session group with less than 6 students 
decrease the discussion throughput, resulting in less 
participative and monotonous sessions. Still, given that 
this strategy was implemented in previous editions of  
the course,8 students were more comfortable in adopt-
ing that system. 
Furthermore, the Biomedical Sciences course cur-
ricular structure provided students the opportunity of  
transposing the information from previously taught 
curricular units. Hence, the active-learning process is 
cumulative and influenced by prior knowledge, provid-
ing the support for the problem analysis, self- directed 
learning and future learning.15, 16
The seminars permitted the enthusiastic participation 
of  the students, who were encouraged to interact with 
the experts by asking questions. Equally, the seminars 
gave to the students, the opportunity of  contacting with 
professionals, exposing them to the labor-market. More-
over, the pharmaceutical industry visit was very interest-
ing and highly motivating for the reason that students 
effectively visualized and materialized the knowhow 
integrated during the theoretical component of  the unit. 
In essence, students felt motivated to learn, particularly 
in the context of  MALA. This multi- faceted teach-
ing method makes it possible to effectively embrace 
competences in the technical, scientific and pedagogic 
areas, given that theoretical students´ knowledge were 
approached by specialists in pharmaceutical areas. 
Moreover, practical competences were acquired dur-
ing the field- trip, promoting the development of  stu-
dents´ technical skills. These so- named “hands on 
experience” schemes promote the students autonomy 
and the feeling of  responsibility for the transmission 
of  knowledge within working groups. Additionally, 
increased research autonomy, synthesis, integration, 
student assessment and discussion of  knowledge were 
markedly noted.
CONCLUSION
In conclusion, the present study fostered the concept 
that the MALA- learning approach should contribute 
to knowledge- enhancing in the pharmaceutical practice 
and could encourage integration of  the students´ learn-
ing skills in the future career, thus stimulating the flex-
ibility in learning. 
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